Tequin and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Tequin (gatifloxacin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Digoxin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Tequin. It is created by eHealthMe based on reports of 4,643 people who have side effects when taking Tequin from the FDA, and is updated regularly.

What is Tequin?

Tequin has active ingredients of gatifloxacin. eHealthMe is studying from 4,645 Tequin users. Check the latest studies of Tequin.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,959 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jun, 26, 2026

4,643 people reported to have side effects when taking Tequin.
Among them, 37 people (0.8%) have Hyperkalemia.

Among these 37 people:

How long have people been on Tequin when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Tequin? *

female: 56.76 %
male: 43.24 %

What is the age of people who have Hyperkalemia when taking Tequin? *

What are other drugs people take besides Tequin? *

What are other side effects people have besides Hyperkalemia? *

Acute Kidney Failure: 11 people, 29.73%
Blood Creatinine Increased: 11 people, 29.73%
Thrombocytopenia (decrease of platelets in blood): 7 people, 18.92%
Chest Pain: 7 people, 18.92%
Hyperglycemia (high blood sugar): 7 people, 18.92%
Atelectasis (partial or complete collapse of the lung): 7 people, 18.92%
Haemoglobin Decreased: 6 people, 16.22%
Fatigue (feeling of tiredness): 6 people, 16.22%
Dyspnea (difficult or laboured breathing): 6 people, 16.22%
Hypotension (abnormally low blood pressure): 6 people, 16.22%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 10.81%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.41%
Cardiac Failure Congestive: 2 people, 5.41%
Neck Pain: 2 people, 5.41%
Enterococcal Infection: 2 people, 5.41%
High Blood Pressure: 2 people, 5.41%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 2.70%
High Blood Cholesterol: 1 person, 2.70%
Bladder Outlet Obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded): 1 person, 2.70%
Erection Problems: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tequin and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tequin:

Tequin (4,645 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Tequin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,959 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gatifloxacin (the active ingredients of Tequin) and Tequin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.